Shin-ichiro Kawaguchi

Shimotsuke, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Journal: Leukemia & lymphoma
Published: September 06, 2026

Efficacy of R-GDP therapy as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Efficacy of R-GDP therapy as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Journal: Leukemia research
Published: March 25, 2026

Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.

Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.

Journal: Leukemia & lymphoma
Published: January 23, 2026

The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias.

The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias.

Journal: Cancer science
Published: December 12, 2025

Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.

Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: October 14, 2025

Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia.

Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia.

Journal: International journal of hematology
Published: July 02, 2025

Risk factors for influenza virus infection in patients with hematological disease.

Risk factors for influenza virus infection in patients with hematological disease.

Journal: Leukemia & lymphoma
Published: April 24, 2025

The combination of venetoclax with dimethyl fumarate synergistically induces apoptosis in AML cells by disrupting mitochondrial integrity through ROS accumulation.

The combination of venetoclax with dimethyl fumarate synergistically induces apoptosis in AML cells by disrupting mitochondrial integrity through ROS accumulation.

Journal: Cell death & disease
Published: November 13, 2024

Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients.

Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients.

Journal: Transplantation and cellular therapy
Published: October 18, 2024

Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

Journal: Bone marrow transplantation
Published: October 09, 2024

Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for secondary treatment.

Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for secondary treatment.

Journal: International journal of hematology
Published: October 04, 2024

Dimethyl Fumarate Negatively Regulates MYC Signaling and Promotes Cell-Cycle Arrest in T-Cells through a GSH-Dependent Mechanism.

Dimethyl Fumarate Negatively Regulates MYC Signaling and Promotes Cell-Cycle Arrest in T-Cells through a GSH-Dependent Mechanism.

Journal: European journal of immunology
Published: July 18, 2024
Showing 1-12 of 46

Last Updated: 09/26/2026